Palisade Bio, Inc.
PALI
$1.87
-$0.05-2.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.90M | -2.87M | -2.78M | -2.23M | -3.34M |
| Total Depreciation and Amortization | 0.00 | 1.00K | 1.00K | 1.00K | 0.00 |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 75.00K | -- | -- |
| Total Other Non-Cash Items | 3.64M | 383.00K | 92.00K | 99.00K | 222.00K |
| Change in Net Operating Assets | 2.11M | -1.07M | 799.00K | -203.00K | 741.00K |
| Cash from Operations | -3.14M | -3.55M | -1.82M | -2.33M | -2.38M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -140.00K | -100.00K | 0.00 | -80.00K | -156.00K |
| Issuance of Common Stock | 131.96M | 3.91M | 4.00K | -- | 4.44M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -490.00K | -445.00K | 0.00 | -178.00K | -120.00K |
| Cash from Financing | 131.33M | 3.36M | 4.00K | -258.00K | 4.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.19M | -190.00K | -1.81M | -2.59M | 1.78M |